Endexx, a US company, recently announced through Globenewswire that its subsidiary, HYLA, has completed the initial review of its premium vegan e-cigarette product and has submitted an application for Tobacco Product Directive (TPD) compliance in Europe.
Hyla has revealed that it plans to launch its products in the following European countries: Austria, Belgium, Czech Republic, France, Germany, Greece, Italy, Slovakia, Spain, Switzerland, and the United Kingdom.
Several countries have already reviewed HYLA's non-nicotine products. TPD registration has fully opened the European market for all of HYLA's products.
According to the introduction, HYLA sells its proprietary soda products made from plant-based ingredients such as non-nicotine, guarana, and levodopa in the market. These soda products come in various flavors and have a consumption volume of 4500 mouths. HYLA's non-nicotine products have quickly gained market share in the preliminary European market. Additionally, HYLA has expanded its product line to include high-quality and fully compliant traditional nicotine products.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
